Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1521973

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1521973

Global Antacids Market Report by Formulation Type Distribution Channel Drug Class Countries and Company Analysis, 2024-2032

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Global Antacids Market Size

Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence of gastrointestinal disorders as well as improved lifestyle, and increased access to health care, which speaks volumes of the global need for effective, and easy to use antacids.

Global Antacids Market Definition

Most antacids work by breaking down the acid found in the stomach in order to help with cases of heartburn, indigestion and acid reflux. They include some required materials like aluminum hydroxide, magnesium hydroxide, calcium carbonate, sodium bicarbonate. Antacids have the capability to counter acidic stomach through a process of making the stomach pH level higher. This assists to reduce pain that is resultant from high levels of gastric acid secretion in the stomach which may culminate to diseases like GERD and peptic ulcer.

Common medicines that are used to treat the symptoms that are associated with heartburn and that give a temporary relief include antacids. They are widely sold within the counter markets, and are available in form of tablets, liquids, and chewable tablets. Apart from the treatment of other disorders of the acid type, antacids may be used to suppress signs of gastritis and contribute to the improvement of the mucosal layer of the stomach. They are rather useful for short-term therapeutic purposes and usually cannot be taken in the long term while treating chronic acid-related diseases when other medicines may be advised by the doctor.

Driving Forces for the Antacids Market

Rising Prevalence of Gastrointestinal Disorders

An increase in the prevalence of gastrointestinal diseases such as acid reflux, GERD, and peptic ulcers is another factor that affects the demand for antacids. Therefore, modern development affects the augmentation of these pathologies due to the improper diet, frequent consumption of fast food, irregular food times, and increased levels of stress. As more people complain of heartburn, indigestion, and 'stomach upset', more people will be in the market for over the counter treatments like antacids. This is evident in the urban workers who had altered their lifestyle leading to various strains which affected their health. Further, the rising incidence of aging people who are vulnerable to various digestion related disorders advanced the market since the elderly will always look for products and services that they can afford to use to solve their digestion problems.

Increasing awareness and accessibility

As the awareness of the options for antacids and their benefits spreads, the market for them is growing. Concerning the public knowledge and availability of health information on the internet and social media, the population is receiving better information on managing simple diarrhea using OTC drugs. Sales and marketing of these products' consumer goods are also assisted by pharmacies and retail stores so that these products may reach the consumer. Moreover, the growth of the electronic market places made the access to the antacids easier for the consumers which improved the accessibility of the product. As individuals gain a better and enhanced understanding of what antacids are and where they can get them, a lot of people would utilize them for acid-related symptoms; therefore, the market balloons in size very quickly.

Advancements in Antacid Formulations

New developments in the preparation of antacid has played most of the vital role in the growth of the market. Today's antacids are available in tablets, liquids, chewable forms and gels to a fit the consumer's taste as well as requirements. New types, like sugar-free, flavoured and the ones that dissolve quickly also increase its appeal to more people which makes antacids a better product. Creating combination products with other useful active substances, such as simethicone for regulated intestinal gas, gives better solutions for the problems with gastrointestinal tracts. They enhance the efficiency and usability of antacids and increase its popularity among the consumers which contributes to market development.

Lifestyle Changes and Dietary Habits

Increased awareness and consciousness among the people about the excessive use of antacids can be another factor, which is also demanding new and improved products or brands of antacids in the global market. Intake of processed foods and high fat diets and products, caffeine and alcohol contribute a lot to heart burn and other cases of indigestion. These complications are aggravated by busy schedules and stress hence the need for quick and efficient remedy solutions. Because of the immediate action of antacids and ease of access, people consider them as a perfect remedy for solving their digestive problems. This trend is especially seen in the more developed economy countries where the populations are often under lots of pressure with their busy daily schedules and harsh working conditions as well as indulging themselves with lots of fatty foods frequency, and therefore, the ever-rising market for antacids.

Asia Pacific Antacids Market

The Asia Pacific antacids market is growing because of the rising prevalence of GID linked with lifestyle factors and food preferences. From these causes of the digestion problem, one may infer that quick growth of urban centers, fast foods consumption, and pressure have played crucial roles in provoking acid reflux and indigestion. In the same regard, increased consumer knowledge on the availability of OTC medications and ease of access to healthcare facilities contributes to the market's growth. Major contributors include China, India and Japan due to the large population of patients as well as growing health industries. Variety of ways has been manufactured to reach out to customers through tablets, liquids and chewable help propel the antacid market. Thus, anticipating the further development of the economy, it is pertinent to note that the Asia Pacific region will experience constant growth in the demand for antacids.

Worldwide Antacids Company Analysis

The Antacids market is dominated by key players such as Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited.

Antacids Company News

In March 2024, ENO, previously owned by GSK Consumer Healthcare and now part of Haleon, introduced a new product called "ENO Chewy Bites," chewable antacids available in Tangy Lemon and Zesty Orange flavors. This expansion offers customers more options for managing stomach discomfort.

In March 2023, WonderbellyTM, a company specializing in clean ingredients and medications for digestive health, introduced its Wonderbelly AntacidTM chewable tablets.

Drug Class - Global Antacids Market in 4 Viewpoints -

1. Proton Pump Inhibitors

2. H2 Antagonist

3. Acid Neutralizers

4. Pro-Motility Agents

Formulation Type - Global Antacids Market in 4 Viewpoints -

1. Tablets

2. Liquid

3. Powder

4. Others

Distribution Channel - Global Antacids Market in 3 Viewpoints -

1. Retail Pharmacy

2. Hospital Pharmacy

3. Online Pharmacy

Geography - Global Antacids Market

North America

1. United States

2. Canada

Europe

1. France

2. Germany

3. Italy

4. Spain

5. United Kingdom

6. Belgium

7. Netherlands

8. Turkey

Asia Pacific

1. China

2. Japan

3. India

4. Australia

5. South Korea

6. Thailand

7. Malaysia

8. Indonesia

9. New Zealand

Latin America

1. Brazil

2. Mexico

3. Argentina

Middle East & Africa

1. South Africa

2. Saudi Arabia

3. United Arab Emirates

Company Insights:

  • Overviews
  • Recent Developments
  • Revenue

Company Analysis:

1. Abbott Laboratories

2. AstraZeneca plc

3. Bayer AG

4. Boehringer Ingelheim International GmbH

5. Dr. Reddy's Laboratories Ltd.

6. GlaxoSmithKline plc

7. Johnson & Johnson

8. Pfizer Inc.

9. Procter & Gamble Company

10. Sanofi S.A.

11. Sun Pharmaceutical Industries Ltd.

12. Takeda Pharmaceutical Company Limited

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Antacids Market

6. Market Share

  • 6.1 Drug Class
  • 6.2 Formulation Type
  • 6.3 Distribution Channel
  • 6.4 Country

7. Drug Class

  • 7.1 Proton Pump Inhibitors
  • 7.2 H2 Antagonist
  • 7.3 Acid Neutralizers
  • 7.4 Pro-Motility Agents

8. Formulation Type

  • 8.1 Tablets
  • 8.2 Liquid
  • 8.3 Powder
  • 8.4 Others

9. Distribution Channel

  • 9.1 Retail Pharmacy
  • 9.2 Hospital Pharmacy
  • 9.3 Online Pharmacy

10. By Country - Global Antacids Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherlands
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 South Korea
    • 10.3.6 Thailand
    • 10.3.7 Malaysia
    • 10.3.8 Indonesia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 South Africa
    • 10.5.2 Saudi Arabia
    • 10.5.3 UAE

11. Porter's Five Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Company Analysis

  • 13.1 Abbott Laboratories
    • 13.1.1 Overview
    • 13.1.2 Recent Developments
    • 13.1.3 Revenue
  • 13.2 AstraZeneca plc
    • 13.2.1 Overview
    • 13.2.2 Recent Developments
    • 13.2.3 Revenue
  • 13.3 Bayer AG
    • 13.3.1 Overview
    • 13.3.2 Recent Developments
    • 13.3.3 Revenue
  • 13.4 Boehringer Ingelheim International GmbH
    • 13.4.1 Overview
    • 13.4.2 Recent Developments
    • 13.4.3 Revenue
  • 13.5 Dr. Reddy's Laboratories Ltd.
    • 13.5.1 Overview
    • 13.5.2 Recent Developments
    • 13.5.3 Revenue
  • 13.6 GlaxoSmithKline plc
    • 13.6.1 Overview
    • 13.6.2 Recent Developments
    • 13.6.3 Revenue
  • 13.7 Johnson & Johnson
    • 13.7.1 Overview
    • 13.7.2 Recent Developments
    • 13.7.3 Revenue
  • 13.8 Pfizer Inc.
    • 13.8.1 Overview
    • 13.8.2 Recent Developments
    • 13.8.3 Revenue
  • 13.9 Procter & Gamble Company
    • 13.9.1 Overview
    • 13.9.2 Recent Developments
    • 13.9.3 Revenue
  • 13.10 Sanofi S.A.
    • 13.10.1 Overview
    • 13.10.2 Recent Developments
    • 13.10.3 Revenue
  • 13.11 Sun Pharmaceutical Industries Ltd.
    • 13.11.1 Overview
    • 13.11.2 Recent Developments
    • 13.11.3 Revenue
  • 13.12 Takeda Pharmaceutical Company Limited
    • 13.12.1 Overview
    • 13.12.2 Recent Developments
    • 13.12.3 Revenue
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!